146 related articles for article (PubMed ID: 11439034)
21. Synthesis of ecteinascidin ET-743 and phthalascidin Pt-650 from cyanosafracin B.
Cuevas C; Pérez M; Martín MJ; Chicharro JL; Fernández-Rivas C; Flores M; Francesch A; Gallego P; Zarzuelo M; de La Calle F; García J; Polanco C; Rodríguez I; Manzanares I
Org Lett; 2000 Aug; 2(16):2545-8. PubMed ID: 10956543
[TBL] [Abstract][Full Text] [Related]
22. Enantioselective synthesis of saframycin A and evaluation of antitumor activity relative to ecteinascidin/saframycin hybrids.
Martinez EJ; Corey EJ
Org Lett; 1999 Jul; 1(1):75-7. PubMed ID: 10822537
[TBL] [Abstract][Full Text] [Related]
23. Solution structure of the (+)-cis-anti-benzo[a]pyrene-dA ([BP]dA) adduct opposite dT in a DNA duplex.
Mao B; Gu Z; Gorin A; Chen J; Hingerty BE; Amin S; Broyde S; Geacintov NE; Patel DJ
Biochemistry; 1999 Aug; 38(33):10831-42. PubMed ID: 10451380
[TBL] [Abstract][Full Text] [Related]
24. Long range 1,4 and 1,6-interstrand cross-links formed by a trinuclear platinum complex. Minor groove preassociation affects kinetics and mechanism of cross-link formation as well as adduct structure.
Hegmans A; Berners-Price SJ; Davies MS; Thomas DS; Humphreys AS; Farrell N
J Am Chem Soc; 2004 Feb; 126(7):2166-80. PubMed ID: 14971952
[TBL] [Abstract][Full Text] [Related]
25. Interference of transcriptional activation by the antineoplastic drug ecteinascidin-743.
Minuzzo M; Marchini S; Broggini M; Faircloth G; D'Incalci M; Mantovani R
Proc Natl Acad Sci U S A; 2000 Jun; 97(12):6780-4. PubMed ID: 10841573
[TBL] [Abstract][Full Text] [Related]
26. Solution structure of an O6-[4-oxo-4-(3-pyridyl)butyl]guanine adduct in an 11 mer DNA duplex: evidence for formation of a base triplex.
Peterson LA; Vu C; Hingerty BE; Broyde S; Cosman M
Biochemistry; 2003 Nov; 42(45):13134-44. PubMed ID: 14609323
[TBL] [Abstract][Full Text] [Related]
27. Solution structure of a guanine-N7-linked complex of the mitomycin C metabolite 2,7-diaminomitosene and DNA. Basis of sequence selectivity.
Subramaniam G; Paz MM; Suresh Kumar G; Das A; Palom Y; Clement CC; Patel DJ; Tomasz M
Biochemistry; 2001 Sep; 40(35):10473-84. PubMed ID: 11523988
[TBL] [Abstract][Full Text] [Related]
28. Unique pattern of ET-743 activity in different cellular systems with defined deficiencies in DNA-repair pathways.
Damia G; Silvestri S; Carrassa L; Filiberti L; Faircloth GT; Liberi G; Foiani M; D'Incalci M
Int J Cancer; 2001 May; 92(4):583-8. PubMed ID: 11304695
[TBL] [Abstract][Full Text] [Related]
29. DNA and non-DNA targets in the mechanism of action of the antitumor drug trabectedin.
David-Cordonnier MH; Gajate C; Olmea O; Laine W; de la Iglesia-Vicente J; Perez C; Cuevas C; Otero G; Manzanares I; Bailly C; Mollinedo F
Chem Biol; 2005 Nov; 12(11):1201-10. PubMed ID: 16298299
[TBL] [Abstract][Full Text] [Related]
30. Solution structural study of a DNA duplex containing the guanine-N7 adduct formed by a cytotoxic platinum-acridine hybrid agent.
Baruah H; Wright MW; Bierbach U
Biochemistry; 2005 Apr; 44(16):6059-70. PubMed ID: 15835895
[TBL] [Abstract][Full Text] [Related]
31. Ecteinascidin-743.
Held-Warmkessel J
Clin J Oncol Nurs; 2003; 7(3):313-9. PubMed ID: 12793338
[TBL] [Abstract][Full Text] [Related]
32. Solution structures of aminofluorene [AF]-stacked conformers of the syn [AF]-C8-dG adduct positioned opposite dC or dA at a template-primer junction.
Gu Z; Gorin A; Hingerty BE; Broyde S; Patel DJ
Biochemistry; 1999 Aug; 38(33):10855-70. PubMed ID: 10451382
[TBL] [Abstract][Full Text] [Related]
33. Solution structure of a DNA duplex containing a cis-diammineplatinum(II) 1,3-d(GTG) intrastrand cross-link, a major adduct in cells treated with the anticancer drug carboplatin.
Teuben JM; Bauer C; Wang AH; Reedijk J
Biochemistry; 1999 Sep; 38(38):12305-12. PubMed ID: 10493798
[TBL] [Abstract][Full Text] [Related]
34. Sequence- and stereospecific conformational rearrangement of styrene oxide adducts located at A x C mismatched base pairs.
Simeonov MF; Tamura PJ; Wilkinson AS; Harris CM; Harris TM; Stone MP
Biochemistry; 2000 Feb; 39(5):924-37. PubMed ID: 10653636
[TBL] [Abstract][Full Text] [Related]
35. Stereochemical origin of opposite orientations in DNA adducts derived from enantiomeric anti-benzo[a]pyrene diol epoxides with different tumorigenic potentials.
Xie XM; Geacintov NE; Broyde S
Biochemistry; 1999 Mar; 38(10):2956-68. PubMed ID: 10074348
[TBL] [Abstract][Full Text] [Related]
36. Solution structure of the aminofluorene-stacked conformer of the syn [AF]-C8-dG adduct positioned at a template-primer junction.
Mao B; Gu Z; Gorin A; Hingerty BE; Broyde S; Patel DJ
Biochemistry; 1997 Nov; 36(47):14491-501. PubMed ID: 9398168
[TBL] [Abstract][Full Text] [Related]
37. Depurinating acylfulvene-DNA adducts: characterizing cellular chemical reactions of a selective antitumor agent.
Gong J; Vaidyanathan VG; Yu X; Kensler TW; Peterson LA; Sturla SJ
J Am Chem Soc; 2007 Feb; 129(7):2101-11. PubMed ID: 17256933
[TBL] [Abstract][Full Text] [Related]
38. Solution conformation of the (-)-cis-anti-benzo[a]pyrenyl-dG adduct opposite dC in a DNA duplex: intercalation of the covalently attached BP ring into the helix with base displacement of the modified deoxyguanosine into the major groove.
Cosman M; Hingerty BE; Luneva N; Amin S; Geacintov NE; Broyde S; Patel DJ
Biochemistry; 1996 Jul; 35(30):9850-63. PubMed ID: 8703959
[TBL] [Abstract][Full Text] [Related]
39. Base selectivity and effects of sequence and DNA secondary structure on the formation of covalent adducts derived from the equine estrogen metabolite 4-hydroxyequilenin.
Kolbanovskiy A; Kuzmin V; Shastry A; Kolbanovskaya M; Chen D; Chang M; Bolton JL; Geacintov NE
Chem Res Toxicol; 2005 Nov; 18(11):1737-47. PubMed ID: 16300383
[TBL] [Abstract][Full Text] [Related]
40. Antitumor activity- and gene expression-based profiling of ecteinascidin Et 743 and phthalascidin Pt 650.
Martinez EJ; Corey EJ; Owa T
Chem Biol; 2001 Dec; 8(12):1151-60. PubMed ID: 11755394
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
